Belgium boy becomes worlds first to beat deadly brain cancer
Lucas Jemeljanova was first diagnosed deadly brain cancer known as diffuse intrinsic pontine glioma (DIPG) at age of six
Lucas Jemeljanova, a 13-year-old boy from Belgium, has accomplished a remarkable feat by becoming the first person in the world to beat a deadly brain cancer known as diffuse intrinsic pontine glioma (DIPG), The Brighter Side reported.
Lucas was first diagnosed with the deadly illness at the age of six. DIPG is a very rare type of brain cancer that statistically kills 98% of patients within five years.
Children with the brain tumour would normally be expected to live nine to 12 months after diagnosis.
Lucas's road to recovery started when he participated in a clinical trial investigating the use of everolimus, a chemotherapeutic medication that is often used to treat brain, kidney, pancreatic, and other malignancies but has not been effectively used to treat DIPG.
Lucas responded well to the treatment, and he saw the tumour gradually go away.
After five years of declared remission, he has now been cancer-free for the last seven years.
At the Gustave Roussy cancer centre in Paris, his doctor Dr Jacques Grill, expressed happiness yet shock at his recovery, saying, "Lucas beat all the odds... his case offers real hope."
It remains unclear why Lucas recovered from the cancer, and scientists are now looking at how his case can help others with the illness in the future.
In the trial, seven other children survived years after their diagnosis, but only Lucas saw his tumour disappear.
-
Is teen anger linked to faster aging? Here’s what the study reveals
-
Teddi Mellencamp reveals medication side-effects landed her in the hospital
-
Billy Porter claims he came back from the dead amid sepsis battle
-
Childhood obesity crisis: 220 million kids may be affected by 2040, report warns
-
Christopher Reid gives update on his ‘heart failure’
-
Paris Hilton's power move to make 'neurodiversity relatable'
-
GLP-1 drugs linked to osteoporosis and gout: New study reveals higher risks
-
Selma Blair talks about how her debilitating disease is 'misunderstood'